Northwestern University Feinberg School of Medicine

Mesulam Cognitive Neurology and Alzheimer’s Disease Center

Clinical Trials

Alzheimer's Disease Core Center
The purpose of the Northwestern Alzheimer’s Disease Center (NADC) research registry is to 1) provide state-of-the-art care to patients with mild cognitive impairment, Alzheimer’s disease and related disorders, and to 2) support clinical and basic research on memory and aging collecting, storing, and disseminating clinical data, brain imaging, and biological samples from research participants to collaborators.
For individuals with dementia who wish to participate in studies:

You must carry a diagnosis of mild cognitive impairment, Alzheimer's disease or other dementia (frontotemporal dementia, primary progressive aphasia, Lewy Body disease and others), established a thorough evaluation prior to enrollment to assure that individuals are eligible to participate. If you think you may have dementia but have not yet been evaluated, you must first undergo a clinical evaluation. This clinical evaluation is not part of the research.

For older individuals without meaningful cognitive decline who wish to participate in studies:
Must meet screening criteria which exclude illnesses that could interfere with cognitive function, and be able to provide the name of a friend or family member who can answer questions about daily activities and whether or not there are observable symptoms of forgetfulness.
Mesulam, Marek-MarselMesulam, Marek-Marsel
STU00023196
More Info

For more information on this study please contact us:

Study Coordinator 312 926 1851